PECAM1 and acute lymphoblastic leukemia: As shown in Fig. 1A, PECAM-1 was conspicuously phosphorylated on tyrosine in Ph+ biphenotypic acute leukemia or ALL cells, which was mostly abolished by treatment with the tyrosine kinase inhibitor imatinib or dasatinib.